How Your Gut Bacteria and Your Body's Cannabis-Like System Talk to Each Other | Research

The takeaway

A comprehensive review maps how the gut microbiome and the expanded endocannabinoid system (endocannabinoidome) communicate bidirectionally, influencing inflammation, metabolic health, mood, and conditions from IBD to Alzheimer's disease.

Gastroenterologists, microbiome researchers, integrative medicine practitioners, and anyone interested in the gut-brain-endocannabinoid connection.

What the researchers found

The gut microbiota and endocannabinoidome interact bidirectionally: gut bacteria influence endocannabinoid levels and receptor expression, while endocannabinoid signaling shapes gut microbial composition and intestinal barrier function. Diet and exercise modulate both systems. These interactions are implicated in IBD, depression, anxiety, Alzheimer's, and metabolic disorders.

Why it matters

The gut-endocannabinoid axis represents a new frontier for understanding how cannabis affects health beyond direct receptor activation. Many of cannabis's effects on mood, inflammation, and metabolism may be mediated through gut microbiome changes.

The numbers in context

Conditions reviewed: IBD, depression, anxiety, Alzheimer's disease, metabolic disorders. Two systems: gut microbiota and endocannabinoidome (expanded ECS including non-classical endocannabinoids). Modulators: diet and physical activity.

How the study worked

Narrative review examining molecular mechanisms and signaling pathways linking the gut microbiota and endocannabinoidome. Analyzes the role of dietary patterns and physical activity in regulating these interactions across multiple disease conditions.

What this study cannot tell us

Narrative review — not systematic. Many findings from animal models with limited human data. Mechanistic understanding is still emerging. Cannot determine if gut microbiome changes are causes or consequences of disease states.

How to read the evidence

Comprehensive narrative review integrating evidence across multiple diseases, but limited by the early stage of this emerging field and lack of systematic methodology.

When this study was published

Published 2025.

The bigger picture

This review positions the gut-endocannabinoid axis as a unifying mechanism for many of cannabis's diverse health effects. If cannabis changes gut bacteria, and gut bacteria change endocannabinoid signaling, the therapeutic implications extend far beyond what direct receptor studies have revealed.

Questions still open

Does cannabis consumption alter gut microbiome composition in humans? Could probiotics enhance or mimic beneficial endocannabinoid effects? Would gut microbiome profiling predict individual responses to cannabis-based therapies?

Common questions

Does cannabis affect your gut bacteria?

Animal studies suggest cannabinoids can alter gut microbial composition. Conversely, gut bacteria influence endocannabinoid levels. This two-way relationship means cannabis may affect health partly through gut microbiome changes, but human evidence is still limited.

What is the endocannabinoidome?

The endocannabinoidome is the expanded version of the endocannabinoid system — including not just classical endocannabinoids (like AEA and 2-AG) and their receptors (CB1, CB2), but also dozens of related lipid mediators, receptors, and enzymes that form a complex signaling network.

Read the original research

Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective.

Frontiers in cellular and infection microbiology, 15, 1566290

View on PubMed ↗Publisher’s paper ↗

Citation

Wang, Yang; Guo, Jing; Mao, Zhiqin; Chen, Ying. (2025). Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective.. Frontiers in cellular and infection microbiology, 15, 1566290. https://doi.org/10.3389/fcimb.2025.1566290